Konica Minolta Inc. has agreed to pay $1bn to acquire Ambry Genetics as the first part of a new precision medicine platform, the companies announced July 6.
“This acquisition is the first in a series of strategic initiatives to secure a leading position for Konica Minolta in precision medicine,”, Konica Minotla Minolta CEO Shoei Yamana said in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?